List of Tables
Table 1. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Specific IgE Blood Based Allergy Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Specific IgE Blood Based Allergy Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Specific IgE Blood Based Allergy Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Specific IgE Blood Based Allergy Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Specific IgE Blood Based Allergy Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specific IgE Blood Based Allergy Testing as of 2024)
Table 11. Global Specific IgE Blood Based Allergy Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Specific IgE Blood Based Allergy Testing Companies Headquarters
Table 13. Global Specific IgE Blood Based Allergy Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Specific IgE Blood Based Allergy Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Specific IgE Blood Based Allergy Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Specific IgE Blood Based Allergy Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Specific IgE Blood Based Allergy Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Specific IgE Blood Based Allergy Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Specific IgE Blood Based Allergy Testing Growth Accelerators and Market Barriers
Table 25. North America Specific IgE Blood Based Allergy Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Specific IgE Blood Based Allergy Testing Growth Accelerators and Market Barriers
Table 27. Europe Specific IgE Blood Based Allergy Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Specific IgE Blood Based Allergy Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Specific IgE Blood Based Allergy Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Specific IgE Blood Based Allergy Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Specific IgE Blood Based Allergy Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Specific IgE Blood Based Allergy Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Specific IgE Blood Based Allergy Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Phadia (Thermo Fisher Scientific) Corporation Information
Table 35. Phadia (Thermo Fisher Scientific) Description and Major Businesses
Table 36. Phadia (Thermo Fisher Scientific) Product Features and Attributes
Table 37. Phadia (Thermo Fisher Scientific) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Phadia (Thermo Fisher Scientific) Revenue Proportion by Product in 2024
Table 39. Phadia (Thermo Fisher Scientific) Revenue Proportion by Application in 2024
Table 40. Phadia (Thermo Fisher Scientific) Revenue Proportion by Geographic Area in 2024
Table 41. Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing SWOT Analysis
Table 42. Phadia (Thermo Fisher Scientific) Recent Developments
Table 43. Medwiss Analytic Corporation Information
Table 44. Medwiss Analytic Description and Major Businesses
Table 45. Medwiss Analytic Product Features and Attributes
Table 46. Medwiss Analytic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Medwiss Analytic Revenue Proportion by Product in 2024
Table 48. Medwiss Analytic Revenue Proportion by Application in 2024
Table 49. Medwiss Analytic Revenue Proportion by Geographic Area in 2024
Table 50. Medwiss Analytic Specific IgE Blood Based Allergy Testing SWOT Analysis
Table 51. Medwiss Analytic Recent Developments
Table 52. Euroimmun Corporation Information
Table 53. Euroimmun Description and Major Businesses
Table 54. Euroimmun Product Features and Attributes
Table 55. Euroimmun Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Euroimmun Revenue Proportion by Product in 2024
Table 57. Euroimmun Revenue Proportion by Application in 2024
Table 58. Euroimmun Revenue Proportion by Geographic Area in 2024
Table 59. Euroimmun Specific IgE Blood Based Allergy Testing SWOT Analysis
Table 60. Euroimmun Recent Developments
Table 61. Quest Diagnostics Corporation Information
Table 62. Quest Diagnostics Description and Major Businesses
Table 63. Quest Diagnostics Product Features and Attributes
Table 64. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Quest Diagnostics Revenue Proportion by Product in 2024
Table 66. Quest Diagnostics Revenue Proportion by Application in 2024
Table 67. Quest Diagnostics Revenue Proportion by Geographic Area in 2024
Table 68. Quest Diagnostics Specific IgE Blood Based Allergy Testing SWOT Analysis
Table 69. Quest Diagnostics Recent Developments
Table 70. Eurofins Biomnis Corporation Information
Table 71. Eurofins Biomnis Description and Major Businesses
Table 72. Eurofins Biomnis Product Features and Attributes
Table 73. Eurofins Biomnis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Eurofins Biomnis Revenue Proportion by Product in 2024
Table 75. Eurofins Biomnis Revenue Proportion by Application in 2024
Table 76. Eurofins Biomnis Revenue Proportion by Geographic Area in 2024
Table 77. Eurofins Biomnis Specific IgE Blood Based Allergy Testing SWOT Analysis
Table 78. Eurofins Biomnis Recent Developments
Table 79. Siemens Healthineers Corporation Information
Table 80. Siemens Healthineers Description and Major Businesses
Table 81. Siemens Healthineers Product Features and Attributes
Table 82. Siemens Healthineers Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Siemens Healthineers Recent Developments
Table 84. Labcorp Corporation Information
Table 85. Labcorp Description and Major Businesses
Table 86. Labcorp Product Features and Attributes
Table 87. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Labcorp Recent Developments
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Product Features and Attributes
Table 92. Novartis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Novartis Recent Developments
Table 94. Omega Diagnostics Corporation Information
Table 95. Omega Diagnostics Description and Major Businesses
Table 96. Omega Diagnostics Product Features and Attributes
Table 97. Omega Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Omega Diagnostics Recent Developments
Table 99. Minaris Medical America Corporation Information
Table 100. Minaris Medical America Description and Major Businesses
Table 101. Minaris Medical America Product Features and Attributes
Table 102. Minaris Medical America Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Minaris Medical America Recent Developments
Table 104. MacroArray Diagnostics Corporation Information
Table 105. MacroArray Diagnostics Description and Major Businesses
Table 106. MacroArray Diagnostics Product Features and Attributes
Table 107. MacroArray Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. MacroArray Diagnostics Recent Developments
Table 109. DST Corporation Information
Table 110. DST Description and Major Businesses
Table 111. DST Product Features and Attributes
Table 112. DST Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. DST Recent Developments
Table 114. HYCOR Biomedical Corporation Information
Table 115. HYCOR Biomedical Description and Major Businesses
Table 116. HYCOR Biomedical Product Features and Attributes
Table 117. HYCOR Biomedical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. HYCOR Biomedical Recent Developments
Table 119. Everlywell Corporation Information
Table 120. Everlywell Description and Major Businesses
Table 121. Everlywell Product Features and Attributes
Table 122. Everlywell Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Everlywell Recent Developments
Table 124. Abionic Corporation Information
Table 125. Abionic Description and Major Businesses
Table 126. Abionic Product Features and Attributes
Table 127. Abionic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Abionic Recent Developments
Table 129. Diagnostic Solutions Laboratory Corporation Information
Table 130. Diagnostic Solutions Laboratory Description and Major Businesses
Table 131. Diagnostic Solutions Laboratory Product Features and Attributes
Table 132. Diagnostic Solutions Laboratory Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Diagnostic Solutions Laboratory Recent Developments
Table 134. MosaicDX Corporation Information
Table 135. MosaicDX Description and Major Businesses
Table 136. MosaicDX Product Features and Attributes
Table 137. MosaicDX Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. MosaicDX Recent Developments
Table 139. Lifelab Testing Corporation Information
Table 140. Lifelab Testing Description and Major Businesses
Table 141. Lifelab Testing Product Features and Attributes
Table 142. Lifelab Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Lifelab Testing Recent Developments
Table 144. HOB Biotech Group Corporation Information
Table 145. HOB Biotech Group Description and Major Businesses
Table 146. HOB Biotech Group Product Features and Attributes
Table 147. HOB Biotech Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. HOB Biotech Group Recent Developments
Table 149. Shenzhen Biocup Biotech Corporation Information
Table 150. Shenzhen Biocup Biotech Description and Major Businesses
Table 151. Shenzhen Biocup Biotech Product Features and Attributes
Table 152. Shenzhen Biocup Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Shenzhen Biocup Biotech Recent Developments
Table 154. Hangzhou Zheda Dixun Biological Gene Engineering Corporation Information
Table 155. Hangzhou Zheda Dixun Biological Gene Engineering Description and Major Businesses
Table 156. Hangzhou Zheda Dixun Biological Gene Engineering Product Features and Attributes
Table 157. Hangzhou Zheda Dixun Biological Gene Engineering Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Hangzhou Zheda Dixun Biological Gene Engineering Recent Developments
Table 159. ACON Biotech Corporation Information
Table 160. ACON Biotech Description and Major Businesses
Table 161. ACON Biotech Product Features and Attributes
Table 162. ACON Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. ACON Biotech Recent Developments
Table 164. Raw Materials Key Suppliers
Table 165. Distributors List
Table 166. Market Trends and Market Evolution
Table 167. Market Drivers and Opportunities
Table 168. Market Challenges, Risks, and Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Specific IgE Blood Based Allergy Testing Product Picture
Figure 2. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. ELISA Product Picture
Figure 4. FEIA Product Picture
Figure 5. Others Product Picture
Figure 6. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Clinical Laboratories
Figure 10. Others
Figure 11. Specific IgE Blood Based Allergy Testing Report Years Considered
Figure 12. Global Specific IgE Blood Based Allergy Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 14. Global Specific IgE Blood Based Allergy Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Region (2020-2031)
Figure 16. Global Specific IgE Blood Based Allergy Testing Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. ELISA Revenue Market Share by Player in 2024
Figure 19. FEIA Revenue Market Share by Player in 2024
Figure 20. Others Revenue Market Share by Player in 2024
Figure 21. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Type (2020-2031)
Figure 22. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Application (2020-2031)
Figure 23. North America Specific IgE Blood Based Allergy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Specific IgE Blood Based Allergy Testing Revenue (US$ Million) in 2024
Figure 25. North America Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Specific IgE Blood Based Allergy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Specific IgE Blood Based Allergy Testing Revenue (US$ Million) in 2024
Figure 32. Europe Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 35. France Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Specific IgE Blood Based Allergy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Specific IgE Blood Based Allergy Testing Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 47. India Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Specific IgE Blood Based Allergy Testing Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Specific IgE Blood Based Allergy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Specific IgE Blood Based Allergy Testing Revenue (US$ Million) in 2024
Figure 55. Central and South America Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Specific IgE Blood Based Allergy Testing Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Specific IgE Blood Based Allergy Testing Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Specific IgE Blood Based Allergy Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Specific IgE Blood Based Allergy Testing Revenue (US$ Million) in 2024
Figure 61. South America Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Specific IgE Blood Based Allergy Testing Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Specific IgE Blood Based Allergy Testing Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Specific IgE Blood Based Allergy Testing Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Specific IgE Blood Based Allergy Testing Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Specific IgE Blood Based Allergy Testing Revenue (2020-2025) & (US$ Million)
Figure 67. Specific IgE Blood Based Allergy Testing Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
